News Industry News CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction May 29, 2024
News Conference News ACC 2023 AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup L.A. McKeown March 09, 2023
News Conference News ACC 2023 Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2 Michael O'Riordan March 09, 2023
News Daily News Korean Registry Casts Fresh Light on Late STEMI Care, Outcomes Shelley Wood April 13, 2021
News Daily News PCI of a Last Remaining Patent Vessel Is Rare and Risky, UK Data Confirm Todd Neale September 08, 2020
Presentation Controversies and Advances 2018 Does Myocardial Viability Predict Improvement With Revascularization? Presenter: Robert O. Bonow November 16, 2018
Presentation CHIP Seattle 2017 How to Assess Viability and Does It Matter Presenter: Eric V. Krieger August 10, 2017
News Conference News EuroPCR 2017 No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan Michael O'Riordan May 17, 2017
News Industry News Beike Biotechnology Publishes New Research Finding Adult Mesenchymal Stem Cells Safe and Effective in Acute Myocardial Infarction July 22, 2015
News Daily News SCAI: Interventionalists Deserve Pay for Emergent STEMI Call Caitlin E. Cox April 26, 2013